Global Knee Cartilage Repairing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Cartilage is the rubbery and soft material present in bone joints and prevents the friction between the bones. The knee cartilage available in the market include fibrocartilage, articular cartilage, and elastic cartilage. Cartilage damage mainly occurs due to the osteoarticular disease, various physiological conditions, and accidents. Damage to the cartilage restricts normal movements of the knee causing pain and often occurs after traumatic and twisting injuries of the knee. Knee cartilage repair is beneficial for the conditions like delayed unions, slow healing wounds, and malunions.
Knee cartilage repairing market is growing at a significant CAGR due to the increase in the geriatric population. The increase in obese population, rising incidence of sports injuries, osteoarthritis, and chondrodystrophic leading are the major factors driving the growth of knee cartilage repairing market over the forecast period. Technological advancements, the rise in number of accidents & related injuries and increasing demand for minimally invasive surgical products are the key factors boosting the growth of knee cartilage repairing market. However, the high cost of therapy and unfavourable reimbursement scenario are the major restraining factors of the knee cartilage repairing market. Complexities of cartilage repair surgeries are also expected to hamper the growth of knee repairing market over the forecast period.
The knee cartilage repairing market is segmented on the basis of treatment modality, by application, procedure type, and end-user.
Based on treatment modality, knee cartilage repairing market has been segmented into the following:
Geographically, knee cartilage repairing market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for a major revenue share in the global market followed by Europe. The factors which are responsible for the growth of knee cartilage repairing market in the region are an increase in geriatric population and rapid degenerative changes of the knees. Furthermore, the growth of the knee cartilage repairing market is partly driven by the expanded access to health insurance coverage in the U.S. through the Medicare and the Medicaid. Rise in prevalence of osteoporosis in France, U.K. (according to National Health Service, over 3 Mn people are affected to osteoporosis in the UK each year), and Germany is anticipated to bolster the knee cartilage repairing market in the Europe region. The presence of skilled healthcare professionals as well as rising bone and joint disorders expected to create the huge demand for surgery products in Germany. Asia Pacific is the most profitable region for knee cartilage repairing market owing to increase in the prevalence of diabetes (according to International Diabetes Federation 2015, approximately 109.6 Mn people were affected with diabetes in China, 1 Mn cases were reported Australia, and 7.2 Mn diabetes cases in Japan), rise in prevalence of osteoporosis in Australia and New Zealand (according to the Osteoporosis Australia over 1 Mn Australians and as per Burden of Osteoporosis in New Zealand (BONZ), the number osteoporosis at different sites in the skeleton was 84,000 cases in 2007, which is expected to reach 116,000 by 2020), increase in demand for elder care and treatment for age related conditions, and rise in medical tourism in Asia Pacific region anticipated to fuel the knee cartilage repairing market over the forecast period. Latin America and Middle East & Africa region are expected to fuel the demand for cartilage repair products during the forecast period due to increase in obese (overweight) population.
Some of the players in knee cartilage repairing market are Medtronic (U.S.), Biomet, Inc. (Zimmer Biomet Inc.) (U.S.), ConMed Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services, Inc.) (U.S.), Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), LifeNet Health, Inc. (U.S.), Anika Therapeutics, Inc. (U.S.), Stryker Corporation (U.S.), and Vericel Corporation (U.S.), to name a few.
In December 2016, FDA approved the autologous cultured chondrocytes on porcine collagen membrane (Maci) by Vericel corporation for symptomatic repair, full-thickness cartilage defects of knee in the adults
In September 2014, DePuy Synthes inked an agreement with Blue Belt Technologies, Inc to access the Sigma HP partial knee on Navio surgical system
REPORT OUTLINE:
Knee cartilage repairing market is growing at a significant CAGR due to the increase in the geriatric population. The increase in obese population, rising incidence of sports injuries, osteoarthritis, and chondrodystrophic leading are the major factors driving the growth of knee cartilage repairing market over the forecast period. Technological advancements, the rise in number of accidents & related injuries and increasing demand for minimally invasive surgical products are the key factors boosting the growth of knee cartilage repairing market. However, the high cost of therapy and unfavourable reimbursement scenario are the major restraining factors of the knee cartilage repairing market. Complexities of cartilage repair surgeries are also expected to hamper the growth of knee repairing market over the forecast period.
The knee cartilage repairing market is segmented on the basis of treatment modality, by application, procedure type, and end-user.
Based on treatment modality, knee cartilage repairing market has been segmented into the following:
- Cell based approaches
- Chondrocyte Transplantation
- Growth factor technology
- Stem cells
- Non-cell based approaches
- Tissue scaffolds
- Cell-free composites
- Hyaline cartilage
- Fibrocartilage
- Arthroscopic Chondroplasty
- Osteochondral grafts transplantation
- Autologous Chondrocyte
- Implants transplant
- Cell-based cartilage resurfacing
- Microfracture
- Others
- Hospitals
- Orthopaedic Clinics
- Ambulatory surgical centres
Geographically, knee cartilage repairing market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for a major revenue share in the global market followed by Europe. The factors which are responsible for the growth of knee cartilage repairing market in the region are an increase in geriatric population and rapid degenerative changes of the knees. Furthermore, the growth of the knee cartilage repairing market is partly driven by the expanded access to health insurance coverage in the U.S. through the Medicare and the Medicaid. Rise in prevalence of osteoporosis in France, U.K. (according to National Health Service, over 3 Mn people are affected to osteoporosis in the UK each year), and Germany is anticipated to bolster the knee cartilage repairing market in the Europe region. The presence of skilled healthcare professionals as well as rising bone and joint disorders expected to create the huge demand for surgery products in Germany. Asia Pacific is the most profitable region for knee cartilage repairing market owing to increase in the prevalence of diabetes (according to International Diabetes Federation 2015, approximately 109.6 Mn people were affected with diabetes in China, 1 Mn cases were reported Australia, and 7.2 Mn diabetes cases in Japan), rise in prevalence of osteoporosis in Australia and New Zealand (according to the Osteoporosis Australia over 1 Mn Australians and as per Burden of Osteoporosis in New Zealand (BONZ), the number osteoporosis at different sites in the skeleton was 84,000 cases in 2007, which is expected to reach 116,000 by 2020), increase in demand for elder care and treatment for age related conditions, and rise in medical tourism in Asia Pacific region anticipated to fuel the knee cartilage repairing market over the forecast period. Latin America and Middle East & Africa region are expected to fuel the demand for cartilage repair products during the forecast period due to increase in obese (overweight) population.
Some of the players in knee cartilage repairing market are Medtronic (U.S.), Biomet, Inc. (Zimmer Biomet Inc.) (U.S.), ConMed Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services, Inc.) (U.S.), Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), LifeNet Health, Inc. (U.S.), Anika Therapeutics, Inc. (U.S.), Stryker Corporation (U.S.), and Vericel Corporation (U.S.), to name a few.
In December 2016, FDA approved the autologous cultured chondrocytes on porcine collagen membrane (Maci) by Vericel corporation for symptomatic repair, full-thickness cartilage defects of knee in the adults
In September 2014, DePuy Synthes inked an agreement with Blue Belt Technologies, Inc to access the Sigma HP partial knee on Navio surgical system
REPORT OUTLINE:
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL KNEE CARTILAGE REPAIRING MARKET INTRODUCTION
2.1. Global Knee Cartilage Repairing Market– Taxonomy
2.2. Global Knee Cartilage Repairing Market–Definitions
2.2.1. Treatment Modality
2.2.2. Application
3. GLOBAL KNEE CARTILAGE REPAIRING MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Knee Cartilage Repairing Market Dynamics – Factors Impact Analysis
3.6. Global Knee Cartilage Repairing Market– Recent Market Introductions
4. GLOBAL KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY TREATMENT MODALITY, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Chondrocyte Transplantation
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Growth Factor Technology
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Stem Cells
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Tissue Scaffolds
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Cell-free Composites
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Hyaline Cartilage
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Fibrocartilage
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY PROCEDURE TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Arthroscopic Chondroplasty
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Osteochondral Grafts Transplantation
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Autologous Chondrocyte
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Implants Transplant
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Cell-based Cartilage Resurfacing
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Microfracture
7.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
7.7. Others
7.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.7.3. Market Opportunity Analysis
8. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Orthopaedic Clinics
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Ambulatory Surgical Centers
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Region, 2017 – 2023
10. NORTH AMERICA KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.1.1. Cell Based Approaches
10.1.1.1.1. Chondrocyte Transplantation
10.1.1.1.2. Growth Factor Technology
10.1.1.1.3. Stem Cells
10.1.1.2. Non-cell Based Approaches
10.1.1.2.1. Tissue Scaffolds
10.1.1.2.2. Cell-free Composites
10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Hyaline Cartilage
10.1.2.2. Fibrocartilage
10.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Arthroscopic Chondroplasty
10.1.3.2. Osteochondral Grafts Transplantation
10.1.3.3. Autologous Chondrocyte
10.1.3.4. Implants Transplant
10.1.3.5. Cell-based Cartilage Resurfacing
10.1.3.6. Microfracture
10.1.3.7. Others
10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Orthopaedic Clinics
10.1.4.3. Ambulatory Surgical Centres
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Country, 2017 – 2023
10.1.7. North America Knee Cartilage Repairing Market Dynamics – Trends
11. EUROPE KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1.1. Cell Based Approaches
11.1.1.1.1. Chondrocyte Transplantation
11.1.1.1.2. Growth Factor Technology
11.1.1.1.3. Stem Cells
11.1.1.2. Non-cell Based Approaches
11.1.1.2.1. Tissue Scaffolds
11.1.1.2.2. Cell-free Composites
11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Hyaline Cartilage
11.1.2.2. Fibrocartilage
11.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Arthroscopic Chondroplasty
11.1.3.2. Osteochondral Grafts Transplantation
11.1.3.3. Autologous Chondrocyte
11.1.3.4. Implants Transplant
11.1.3.5. Cell-based Cartilage Resurfacing
11.1.3.6. Microfracture
11.1.3.7. Others
11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Orthopaedic Clinics
11.1.4.3. Ambulatory Surgical Centres
11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Country, 2017 – 2023
11.1.7. Europe Knee Cartilage Repairing Market Dynamics – Trends
12. ASIA-PACIFIC KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1.1. Cell Based Approaches
12.1.1.1.1. Chondrocyte Transplantation
12.1.1.1.2. Growth Factor Technology
12.1.1.1.3. Stem Cells
12.1.1.2. Non-cell Based Approaches
12.1.1.2.1. Tissue Scaffolds
12.1.1.2.2. Cell-free Composites
12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Hyaline Cartilage
12.1.2.2. Fibrocartilage
12.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Arthroscopic Chondroplasty
12.1.3.2. Osteochondral Grafts Transplantation
12.1.3.3. Autologous Chondrocyte
12.1.3.4. Implants Transplant
12.1.3.5. Cell-based Cartilage Resurfacing
12.1.3.6. Microfracture
12.1.3.7. Others
12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Orthopaedic Clinics
12.1.4.3. Ambulatory Surgical Centres
12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Country, 2017 – 2023
12.1.7. Asia-Pacific Knee Cartilage Repairing Market Dynamics – Trends
13. LATIN AMERICA KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1.1. Cell Based Approaches
13.1.1.1.1. Chondrocyte Transplantation
13.1.1.1.2. Growth Factor Technology
13.1.1.1.3. Stem Cells
13.1.1.2. Non-cell Based Approaches
13.1.1.2.1. Tissue Scaffolds
13.1.1.2.2. Cell-free Composites
13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Hyaline Cartilage
13.1.2.2. Fibrocartilage
13.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Arthroscopic Chondroplasty
13.1.3.2. Osteochondral Grafts Transplantation
13.1.3.3. Autologous Chondrocyte
13.1.3.4. Implants Transplant
13.1.3.5. Cell-based Cartilage Resurfacing
13.1.3.6. Microfracture
13.1.3.7. Others
13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Orthopaedic Clinics
13.1.4.3. Ambulatory Surgical Centres
13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, End User, and Country, 2017 – 2023
13.1.7. Latin America Knee Cartilage Repairing Market Dynamics – Trends
14. MIDDLE EAST & AFRICA KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.1.1. Cell Based Approaches
14.1.1.1.1. Chondrocyte Transplantation
14.1.1.1.2. Growth Factor Technology
14.1.1.1.3. Stem Cells
14.1.1.2. Non-cell Based Approaches
14.1.1.2.1. Tissue Scaffolds
14.1.1.2.2. Cell-free Composites
14.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Hyaline Cartilage
14.1.2.2. Fibrocartilage
14.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Arthroscopic Chondroplasty
14.1.3.2. Osteochondral Grafts Transplantation
14.1.3.3. Autologous Chondrocyte
14.1.3.4. Implants Transplant
14.1.3.5. Cell-based Cartilage Resurfacing
14.1.3.6. Microfracture
14.1.3.7. Others
14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Orthopaedic Clinics
14.1.4.3. Ambulatory Surgical Centres
14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. MEA Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Country, 2017 – 2023
14.1.7. MEA Knee Cartilage Repairing Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Medtronic (U.S.)
15.2.2. Biomet, Inc. (Zimmer Biomet Inc.) (U.S.)
15.2.3. ConMed Corporation (U.S.)
15.2.4. Depuy Synthes (Johnson and Johnson Services, Inc.) (U.S.)
15.2.5. Arthrex, Inc. (U.S.)
15.2.6. Smith & Nephew PLC (U.K.)
15.2.7. LifeNet Health, Inc. (U.S.)
15.2.8. Anika Therapeutics, Inc. (U.S.)
15.2.9. Stryker Corporation (U.S.)
15.2.10. Vericel Corporation (U.S.)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL KNEE CARTILAGE REPAIRING MARKET INTRODUCTION
2.1. Global Knee Cartilage Repairing Market– Taxonomy
2.2. Global Knee Cartilage Repairing Market–Definitions
2.2.1. Treatment Modality
2.2.2. Application
3. GLOBAL KNEE CARTILAGE REPAIRING MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Knee Cartilage Repairing Market Dynamics – Factors Impact Analysis
3.6. Global Knee Cartilage Repairing Market– Recent Market Introductions
4. GLOBAL KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY TREATMENT MODALITY, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Chondrocyte Transplantation
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Growth Factor Technology
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Stem Cells
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Tissue Scaffolds
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Cell-free Composites
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Hyaline Cartilage
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Fibrocartilage
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY PROCEDURE TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Arthroscopic Chondroplasty
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Osteochondral Grafts Transplantation
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Autologous Chondrocyte
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Implants Transplant
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Cell-based Cartilage Resurfacing
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Microfracture
7.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
7.7. Others
7.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.7.3. Market Opportunity Analysis
8. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Orthopaedic Clinics
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Ambulatory Surgical Centers
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL KNEE CARTILAGE REPAIRING MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Region, 2017 – 2023
10. NORTH AMERICA KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.1.1. Cell Based Approaches
10.1.1.1.1. Chondrocyte Transplantation
10.1.1.1.2. Growth Factor Technology
10.1.1.1.3. Stem Cells
10.1.1.2. Non-cell Based Approaches
10.1.1.2.1. Tissue Scaffolds
10.1.1.2.2. Cell-free Composites
10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Hyaline Cartilage
10.1.2.2. Fibrocartilage
10.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Arthroscopic Chondroplasty
10.1.3.2. Osteochondral Grafts Transplantation
10.1.3.3. Autologous Chondrocyte
10.1.3.4. Implants Transplant
10.1.3.5. Cell-based Cartilage Resurfacing
10.1.3.6. Microfracture
10.1.3.7. Others
10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Orthopaedic Clinics
10.1.4.3. Ambulatory Surgical Centres
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Country, 2017 – 2023
10.1.7. North America Knee Cartilage Repairing Market Dynamics – Trends
11. EUROPE KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1.1. Cell Based Approaches
11.1.1.1.1. Chondrocyte Transplantation
11.1.1.1.2. Growth Factor Technology
11.1.1.1.3. Stem Cells
11.1.1.2. Non-cell Based Approaches
11.1.1.2.1. Tissue Scaffolds
11.1.1.2.2. Cell-free Composites
11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Hyaline Cartilage
11.1.2.2. Fibrocartilage
11.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Arthroscopic Chondroplasty
11.1.3.2. Osteochondral Grafts Transplantation
11.1.3.3. Autologous Chondrocyte
11.1.3.4. Implants Transplant
11.1.3.5. Cell-based Cartilage Resurfacing
11.1.3.6. Microfracture
11.1.3.7. Others
11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Orthopaedic Clinics
11.1.4.3. Ambulatory Surgical Centres
11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Country, 2017 – 2023
11.1.7. Europe Knee Cartilage Repairing Market Dynamics – Trends
12. ASIA-PACIFIC KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1.1. Cell Based Approaches
12.1.1.1.1. Chondrocyte Transplantation
12.1.1.1.2. Growth Factor Technology
12.1.1.1.3. Stem Cells
12.1.1.2. Non-cell Based Approaches
12.1.1.2.1. Tissue Scaffolds
12.1.1.2.2. Cell-free Composites
12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Hyaline Cartilage
12.1.2.2. Fibrocartilage
12.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Arthroscopic Chondroplasty
12.1.3.2. Osteochondral Grafts Transplantation
12.1.3.3. Autologous Chondrocyte
12.1.3.4. Implants Transplant
12.1.3.5. Cell-based Cartilage Resurfacing
12.1.3.6. Microfracture
12.1.3.7. Others
12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Orthopaedic Clinics
12.1.4.3. Ambulatory Surgical Centres
12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Country, 2017 – 2023
12.1.7. Asia-Pacific Knee Cartilage Repairing Market Dynamics – Trends
13. LATIN AMERICA KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1.1. Cell Based Approaches
13.1.1.1.1. Chondrocyte Transplantation
13.1.1.1.2. Growth Factor Technology
13.1.1.1.3. Stem Cells
13.1.1.2. Non-cell Based Approaches
13.1.1.2.1. Tissue Scaffolds
13.1.1.2.2. Cell-free Composites
13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Hyaline Cartilage
13.1.2.2. Fibrocartilage
13.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Arthroscopic Chondroplasty
13.1.3.2. Osteochondral Grafts Transplantation
13.1.3.3. Autologous Chondrocyte
13.1.3.4. Implants Transplant
13.1.3.5. Cell-based Cartilage Resurfacing
13.1.3.6. Microfracture
13.1.3.7. Others
13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Orthopaedic Clinics
13.1.4.3. Ambulatory Surgical Centres
13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, End User, and Country, 2017 – 2023
13.1.7. Latin America Knee Cartilage Repairing Market Dynamics – Trends
14. MIDDLE EAST & AFRICA KNEE CARTILAGE REPAIRING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Treatment Modality Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.1.1. Cell Based Approaches
14.1.1.1.1. Chondrocyte Transplantation
14.1.1.1.2. Growth Factor Technology
14.1.1.1.3. Stem Cells
14.1.1.2. Non-cell Based Approaches
14.1.1.2.1. Tissue Scaffolds
14.1.1.2.2. Cell-free Composites
14.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Hyaline Cartilage
14.1.2.2. Fibrocartilage
14.1.3. Procedure Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Arthroscopic Chondroplasty
14.1.3.2. Osteochondral Grafts Transplantation
14.1.3.3. Autologous Chondrocyte
14.1.3.4. Implants Transplant
14.1.3.5. Cell-based Cartilage Resurfacing
14.1.3.6. Microfracture
14.1.3.7. Others
14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Orthopaedic Clinics
14.1.4.3. Ambulatory Surgical Centres
14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. MEA Knee Cartilage Repairing Market- Opportunity Analysis Index - By Treatment Modality, By Application, By Procedure Type, By End User, and Country, 2017 – 2023
14.1.7. MEA Knee Cartilage Repairing Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Medtronic (U.S.)
15.2.2. Biomet, Inc. (Zimmer Biomet Inc.) (U.S.)
15.2.3. ConMed Corporation (U.S.)
15.2.4. Depuy Synthes (Johnson and Johnson Services, Inc.) (U.S.)
15.2.5. Arthrex, Inc. (U.S.)
15.2.6. Smith & Nephew PLC (U.K.)
15.2.7. LifeNet Health, Inc. (U.S.)
15.2.8. Anika Therapeutics, Inc. (U.S.)
15.2.9. Stryker Corporation (U.S.)
15.2.10. Vericel Corporation (U.S.)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
